Differential regulation of macrophage inflammatory activation by fibrin and fibrinogen.
Fibrin is a major component of the provisional extracellular matrix formed during tissue repair following injury, and enables cell infiltration and anchoring at the wound site. Macrophages are dynamic regulators of this process, advancing and resolving inflammation in response to cues in their microenvironment. Although much is known about how soluble factors such as cytokines and chemokines regulate macrophage polarization, less is understood about how insoluble and adhesive cues, specifically the blood coagulation matrix fibrin, influence macrophage behavior. In this study, we observed that fibrin and its precursor fibrinogen elicit distinct macrophage functions. Culturing macrophages on fibrin gels fabricated by combining fibrinogen with thrombin stimulated secretion of the anti-inflammatory cytokine, interleukin-10 (IL-10). In contrast, exposure of macrophages to soluble fibrinogen stimulated high levels of inflammatory cytokine tumor necrosis factor alpha (TNF-α). Macrophages maintained their anti-inflammatory behavior when cultured on fibrin gels in the presence of soluble fibrinogen. In addition, adhesion to fibrin matrices inhibited TNF-α production in response to stimulation with LPS and IFN-γ, cytokines known to promote inflammatory macrophage polarization. Our data demonstrate that fibrin exerts a protective effect on macrophages, preventing inflammatory activation by stimuli including fibrinogen, LPS, and IFN-γ. Together, our study suggests that the presentation of fibrin(ogen) may be a key switch in regulating macrophage phenotype behavior, and this feature may provide a valuable immunomodulatory strategy for tissue healing and regeneration.



Fibrin is a fibrous protein resulting from blood clotting and provides a provisional matrix into which cells migrate and to which they adhere during wound healing. Macrophages play an important role in this process, and are needed for both advancing and resolving inflammation. We demonstrate that culture of macrophages on fibrin matrices exerts an anti-inflammatory effect, whereas the soluble precursor fibrinogen stimulates inflammatory activation. Moreover, culture on fibrin completely abrogates inflammatory signaling caused by fibrinogen or known inflammatory stimuli including LPS and IFN-γ. Together, these studies show that the presentation of fibrin(ogen) is important for regulating a switch between macrophage pro- and anti-inflammatory behavior.
Department of Biomedical Engineering, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; Department of Chemical Engineering and Materials Science, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; The Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States.
Jessica Y
JY
Hsieh
Department of Biomedical Engineering, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; Department of Chemical Engineering and Materials Science, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; The Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States.
Tim D
TD
Smith
Department of Biomedical Engineering, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; Department of Chemical Engineering and Materials Science, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; The Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States.
Vijaykumar S
VS
Meli
Department of Biomedical Engineering, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; Department of Chemical Engineering and Materials Science, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; The Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States.
Thi N
TN
Tran
Department of Biomedical Engineering, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; Department of Chemical Engineering and Materials Science, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; The Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States.
Elliot L
EL
Botvinick
Department of Biomedical Engineering, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; Department of Chemical Engineering and Materials Science, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States; The Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California, Irvine, 2412 Engineering Hall, Irvine, CA 92697-2730, United States. Electronic address: wendy.liu@uci.edu.
Wendy F
WF
Liu
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D002448:Cell Adhesion / Q000187:drug effects; D016764:Cell Polarity / Q000187:drug effects; D048430:Cell Shape / Q000187:drug effects; D003094:Collagen / Q000494:pharmacology; D016207:Cytokines / Q000378:metabolism; D019610:Cytoprotection / Q000187:drug effects; D003599:Cytoskeleton / Q000187:drug effects / Q000378:metabolism; D005260:Female; D005337:Fibrin / Q000494:pharmacology*; D005340:Fibrinogen / Q000494:pharmacology*; D005782:Gels; D007249:Inflammation / Q000473:pathology*; D007371:Interferon-gamma; D008070:Lipopolysaccharides; D008262:Macrophage Activation / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects / Q000473:pathology*; D008810:Mice, Inbred C57BL; D051381:Rats
D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D016207:Cytokines; D005782:Gels; D008070:Lipopolysaccharides; D007371:Interferon-gamma; D005337:Fibrin; D005340:Fibrinogen; D003094:Collagen
Fibrin; Fibrinogen; Macrophage; Polarization
J Exp Med. 2007 Aug 6;204(8):1999-2008
17664291
J Immunol. 2001 Sep 1;167(5):2887-94
11509636
World J Surg. 2010 Apr;34(4):632-4
19820991
J Biol Chem. 1990 Jul 25;265(21):12119-22
1973686
Nat Immunol. 2010 Aug;11(8):734-42
20639876
J Neuroinflammation. 2011 May 26;8:58
21615896
Nat Biotechnol. 2013 Jun;31(6):553-6
23666011
Blood. 2003 Feb 15;101(4):1243-8
12393393
J Biol Chem. 1998 Aug 28;273(35):22519-27
9712878
J Immunol. 1993 Apr 1;150(7):2972-80
8095957
Plast Reconstr Surg. 2001 Nov;108(6):1713-26
11711954
Cell Mol Life Sci. 2015 Apr;72(7):1303-16
25504084
Exp Cell Res. 2014 Mar 10;322(1):1-11
24378385
Adv Healthc Mater. 2014 Jul;3(7):989-94
24573988
Am J Pathol. 2009 Dec;175(6):2454-62
19850888
Am J Pathol. 2011 Jan;178(1):19-25
21224038
Nat Commun. 2012;3:1227
23187627
ACS Biomater Sci Eng. 2015 Jul 13;1(7):481-493
26280020
Tissue Eng Part B Rev. 2008 Jun;14(2):199-215
18544016
Inflamm Res. 2002 Mar;51(3):119-28
12005202
Biochem Biophys Res Commun. 1999 Nov 2;264(3):630-4
10543983
J Biol Chem. 2004 Oct 22;279(43):44897-906
15304494
Lab Invest. 1986 Jan;54(1):62-70
3941542
Science. 2016 Apr 15;352(6283):366-70
27081073
Blood. 2001 Aug 15;98(4):1231-8
11493475
Immunity. 2010 Apr 23;32(4):518-30
20362473
Biomaterials. 2014 Oct;35(30):8605-12
25043569
ACS Appl Mater Interfaces. 2015 Dec 30;7(51):28665-72
26605491
J Neurosci. 2010 Apr 28;30(17):5843-54
20427645
Int J Clin Pract. 2008 Jul;62(7):1070-5
17916180
Semin Immunopathol. 2012 Jan;34(1):43-62
22037947
Transfusion. 2012 Oct;52(10):2243-55
22612730
Acta Biomater. 2014 Apr;10(4):1502-14
24056097
Stroke. 2005 Dec;36(12):2637-41
16269641
Eur Heart J. 2003 Mar;24(6):499-500
12643881
J Immunol. 2010 Apr 1;184(7):3964-77
20176743
J Biol Chem. 1993 Jan 25;268(3):1847-53
8093615
Arteriosclerosis. 1989 Jan-Feb;9(1):109-21
2643421
Biochemistry. 2002 Oct 29;41(43):12942-51
12390020
Acta Biomater. 2015 Sep;24:74-86
26093069
Biomater Sci. 2015 Mar;3(3):424-41
26222286
J Immunol. 1995 Feb 15;154(4):1879-87
7836771
J R Soc Interface. 2009 Jan 6;6(30):1-10
18801715
J Exp Med. 2007 Mar 19;204(3):571-82
17339406
J Leukoc Biol. 2010 Jan;87(1):59-67
20052800
Minerva Cardioangiol. 2000 Apr-May;48(4-5):97-102
10959145
Nat Biotechnol. 2016 Mar;34(3):345-52
26807527
Biochemistry. 1999 May 4;38(18):5872-7
10231539
J Biomed Mater Res A. 2012 Jun;100(6):1375-86
22407522
Med Hypotheses. 2000 Mar;54(3):456-60
10783488
Blood. 2006 May 15;107(10 ):3883-91
16434491
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17253-8
24101477
J Control Release. 2010 Nov 20;148(1):49-55
20637815
Nucleic Acids Res. 2012 Apr;40(7):e51
22228834
J Biol Methods. 2014;1(2):null
25606571
Blood. 2000 Nov 15;96(10):3302-9
11071621
Biochemistry. 2003 Aug 12;42(31):9365-73
12899623
Adv Protein Chem. 2005;70:247-99
15837518
Trends Immunol. 2004 Dec;25(12):677-86
15530839
Angiogenesis. 2012 Jun;15(2):253-64
22382584
Proc Natl Acad Sci U S A. 1988 Oct;85(20):7734-8
2971974
Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):1044-8
1671533
Atherosclerosis. 1996 Apr 5;121(2):185-91
9125293
J Immunol. 2006 Nov 15;177(10):7303-11
17082649
Drug Intell Clin Pharm. 1988 Dec;22(12):946-52
2468466
Nat Commun. 2015 Sep 10;6:8164
26353940
Expert Rev Mol Med. 2011 Jul 11;13:e23
21740602
J Control Release. 2014 Dec 28;196:1-8
25284479
Biomaterials. 2015 Apr;46:131-40
25678122
Immunity. 2014 Feb 20;40(2):274-88
24530056
Science. 1997 Apr 4;276(5309):75-81
9082989
Cancer Metastasis Rev. 1992 Nov;11(3-4):283-90
1423819
Blood. 2002 Feb 1;99(3):1053-9
11807012
Biomaterials. 2014 Aug;35(25):6838-49
24856104
Exp Cell Res. 2013 Oct 1;319(16):2409-17
23800466
Blood. 2013 Mar 7;121(10):1712-9
23305734